Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-01-11
2000-05-30
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514316, 514318, 544357, 544360, 544364, 544393, 546189, 546194, A61K 31495, A61K 31445, C07D40112, C07D40114
Patent
active
060691433
ABSTRACT:
This invention relates to compounds of the formula: ##STR1## which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such activity, and a method for inhibiting platelet aggregation.
REFERENCES:
patent: 5700801 (1997-12-01), Pieper et al.
patent: 5756519 (1998-05-01), Bondinell et al.
patent: 5786371 (1998-07-01), Tsaklakidis et al.
patent: 5814636 (1998-09-01), Katano et al.
Himmelsbach et al, Chemical Abstracts, vol. 121 No. 133976, (Abstract for DE 4241632), 1994.
Pieper et al, Chemical Abstracts, vol. 125, No. 195688 (Abstract for WO 96 20173, Jul. 4, 1996).
Ali Fadia El-Fehail
Bondinell William Edward
Calvo Raul Rolando
Ku Thomas Wen-Fu
Miller William Henry
Bernhardt Emily
Kinzig Charles M.
McCarthy Mary E.
SmithKline Beecham Corporation
Venetianer Stephen
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1910546